Jennison Associates’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-269,131
| Closed | -$3.56M | – | 573 |
|
|
2024
Q4 | $3.56M | Buy |
269,131
+4,242
| +2% | +$56.2K | ﹤0.01% | 430 |
|
|
2024
Q3 | $8.87M | Buy |
+264,889
| New | +$8.87M | 0.01% | 395 |
|
|
2023
Q1 | – | Sell |
-19,802
| Closed | -$614K | – | 588 |
|
|
2022
Q4 | $614K | Buy |
+19,802
| New | +$614K | ﹤0.01% | 550 |
|
|
2019
Q3 | – | Sell |
-162,422
| Closed | -$9.16M | – | 638 |
|
|
2019
Q2 | $9.16M | Buy |
162,422
+66,031
| +69% | +$3.73M | 0.01% | 437 |
|
|
2019
Q1 | $7.04M | Sell |
96,391
-9
| -0% | -$657 | 0.01% | 452 |
|
|
2018
Q4 | $6.15M | Sell |
96,400
-2,193
| -2% | -$140K | 0.01% | 471 |
|
|
2018
Q3 | $9.84M | Buy |
+98,593
| New | +$9.84M | 0.01% | 469 |
|